313 related articles for article (PubMed ID: 15329192)
1. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?
Frezza EE
Obes Surg; 2004 Aug; 14(7):999-1005. PubMed ID: 15329192
[TBL] [Abstract][Full Text] [Related]
2. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
Gumbs AA; Modlin IM; Ballantyne GH
Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
[TBL] [Abstract][Full Text] [Related]
3. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
4. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
[TBL] [Abstract][Full Text] [Related]
5. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
Vaag A
Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
[TBL] [Abstract][Full Text] [Related]
6. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
Mingrone G
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
[TBL] [Abstract][Full Text] [Related]
7. Extrapancreatic effects of GIP and GLP-1.
Vella A; Rizza RA
Horm Metab Res; 2004; 36(11-12):830-6. PubMed ID: 15655715
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.
Guidone C; Manco M; Valera-Mora E; Iaconelli A; Gniuli D; Mari A; Nanni G; Castagneto M; Calvani M; Mingrone G
Diabetes; 2006 Jul; 55(7):2025-31. PubMed ID: 16804072
[TBL] [Abstract][Full Text] [Related]
9. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
10. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
Spector D; Shikora S
Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
[TBL] [Abstract][Full Text] [Related]
11. Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
Ranganath LR
J Clin Pathol; 2008 Apr; 61(4):401-9. PubMed ID: 18375745
[TBL] [Abstract][Full Text] [Related]
12. Incretins, diabetes, and bariatric surgery: a review.
Fetner R; McGinty J; Russell C; Pi-Sunyer FX; Laferrère B
Surg Obes Relat Dis; 2005; 1(6):589-97; discussion 597-8. PubMed ID: 16925299
[No Abstract] [Full Text] [Related]
13. Bariatric surgery and the gut-brain communication--the state of the art three years later.
Diniz Mde F; Azeredo Passos VM; Diniz MT
Nutrition; 2010 Oct; 26(10):925-31. PubMed ID: 20392599
[TBL] [Abstract][Full Text] [Related]
14. Gut hormones and the control of appetite.
Small CJ; Bloom SR
Trends Endocrinol Metab; 2004 Aug; 15(6):259-63. PubMed ID: 15358278
[TBL] [Abstract][Full Text] [Related]
15. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
[TBL] [Abstract][Full Text] [Related]
16. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
Dupre J
Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
[TBL] [Abstract][Full Text] [Related]
17. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
Valverde I; Puente J; Martín-Duce A; Molina L; Lozano O; Sancho V; Malaisse WJ; Villanueva-Peñacarrillo ML
Obes Surg; 2005 Mar; 15(3):387-97. PubMed ID: 15826475
[TBL] [Abstract][Full Text] [Related]
18. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?
Andreelli F; Amouyal C; Magnan C; Mithieux G
Diabetes Metab; 2009 Dec; 35(6 Pt 2):499-507. PubMed ID: 20152734
[TBL] [Abstract][Full Text] [Related]
19. Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide.
Meier JJ; Nauck MA
Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):587-606. PubMed ID: 15533777
[TBL] [Abstract][Full Text] [Related]
20. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
